HighTower Advisors »

Akari Therapeutics Plc Sponsored shares owned by HighTower Advisors

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $80k 79k 1.01
2025-06-30 $93k 79k 1.17

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Akari Therapeutics Plc Sponsored

Cresset Asset Management
Palo Alto Investors
HighTower Advisors
Omnia Family Wealth
HPM Partners
Virtu Financial
Two Sigma Securities
Independent Advisor Alliance
Accent Capital Management
Goss Wealth Management
UBS Group
Truvestments Capital
EverSource Wealth Advisors
Cornerstone Planning Group
Morgan Stanley

View all funds holding Akari Therapeutics Plc Sponsored